Biotechnology / Funding / Science / Venture capital

This Penn-founded biotech company specializing in human ‘organs on chip’ raised $4M

Vivodyne's goal is to lower the bar for labs and scientists to test their own research.

Vivodyne's Dan Huh and Andrei Georgescu. (Courtesy photo)

A University of Pennsylvania-founded biotech company that helps scientists test drugs and therapeutics has raised $4 million in order to more widely adopt their platform that embraces “organs on chip” technology.

Research into potential drugs is usually performed first on mice, and success is only found in a fraction of humans once implemented in clinical trials, Andrei Georgescu, cofounder and CEO of Vivodyne, told The genetic makeup just isn’t similar enough. But technology that allows scientists to test therapies on lab-grown human organs called “organs on chip” is allowing for testing without human subjects.

The organs on chip allow for a drug to react to tissue in a more similar way to the body than it would in a petri dish, Georgescu said. Cells sense their environment very well, he added.

“We’re making the environment more complicated, making its spacial features complicated enough to match the native complexity of the organs,” he said. “When [cells] sense a softer environment, they start to behave more realistically. Their response to the drug is more realistic.”

Vivodyne’s platform was originally developed at Penn in the BIOLines Lab, which is directed by Dr. Dan Huh, who cofounded the company with Georgescu. Years ago, Huh and other scientists developed tools to emulate human organs in living benchtop platforms, but they were hard to get right, he said.

“They’re a bit different each time, and they’re made from materials that don’t interface well with the enormous scale and consistency that drug companies need,” Huh said in a statement. “With Vivodyne, we’ve finally bridged that gap by automating every aspect of cultivating, testing, and analyzing these tissues’ responses to drugs and environmental stimuli with superhuman speed and precision.”

Vivodyne cofounder and CEO Andrei Georgescu. (Courtesy photo)

Vivodyne formed at the end of last year, and this spring raised this $4 million seed round led by LA-based Kairos Ventures. The team of six will grow likely to about 17 or 18 people within the next year, and the company is moving into a space at the Curtis Center in Old City.

The main goal with the funding is to lower the bar for labs and scientists to test their own research instead of just the specialists who make these chips, Georgescu said.

“The most important thing is to make a usable product that customers can use to develop their research and discoveries,” the CEO said. “We focus on the product, and the rest will follow.”

Companies: University of Pennsylvania

Before you go...

Please consider supporting to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!


Philly-area gold exchange startup reaches $1M in revenue just 10 months after launch

Cal Ripken Jr. essay: The MLB legend explains his drive to build STEM centers in schools across the nation

Calling all parents with too much toy clutter: This Philly startup can help

He started at Neya as an intern. 10 years later, he’s director of robotics — and loving life

Technically Media